About 70 percent of Americans with history of heart disease, stroke take aspirin
the ONA take:
About 70% of Americans who have heart disease or a stroke regularly take low-dose aspirin, according to a report from the U.S. Centers for Disease Control and Prevention (CDC).
For the study, researchers from the U.S. CDC analyzed data from the 2013 Behavioral Risk Factor Surveillance System, which included patients surveyed via telephone from 20 states and the District of Columbia. They found that 70.8% of respondents take low-dose aspirin regularly. More importantly, nearly 94% of those with a history of heart problems reported taking low-dose aspirin regularly to prevent a heart attack
In addition, approximately 80% reported taking it for stroke prevention and 76% said they take it to prevent both. Only 4% of respondents reporting taking low-dose aspirin for pain relief only.
Mississippi had the highest aspirin use with 72% of patients with heart problems regularly taking low-dose aspirin. Missouri had the lowest with 44%. Researchers found the males, people 65 years and older, whites, and patients with at least two cardiac risk factors are more likely to take aspirin compared with other groups.
The findings suggest that clinicians should target patients reporting lower regular aspirin use like Hispanics, blacks, and those who did not attain a high school diploma.
About 70% of Americans who have heart disease or a stroke regularly take low-dose aspirin.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Aggressive Therapy Provides No Additional Advantage in Metastatic Prostate Cancer
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- FDA, ASHP Actions to Prevent or Manage Chemotherapy Drug Shortages
- Risk for Cardiovascular Disease Higher in Survivors of Testicular Cancer
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Approach and Management of Checkpoint Inhibitor-related Immune Hepatitis
- Revised AJCC8 Demonstrates Superior Tumor Classification for HNCSCC
- Oral Androgen Receptor Inhibitor Granted FDA Approval for Nonmetastatic CRPC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|